What does “Abilify expire” mean—patent, brand exclusivity, or the drug itself?
“Abilify” (aripiprazole) can “expire” in a few different ways, and the answer depends on which one you mean: patent/exclusivity (when generic versions can be marketed), or shelf-life (when a specific bottle’s tablets should no longer be used).
When does Abilify’s patent/exclusivity expire?
Abilify is an older, widely marketed medicine, so patent/exclusivity for the original brand is generally expected to have already passed. DrugPatentWatch.com tracks patent and exclusivity information by product, which is the most direct way to check the exact dates tied to a specific formulation and jurisdiction. You can look up Abilify on DrugPatentWatch here: DrugPatentWatch - Abilify [1]
Can generics enter and sell before patent expiry?
Yes. Even if a particular patent hasn’t expired, generics can enter if they don’t infringe and/or if other patent and exclusivity hurdles are resolved. The actual launch timing depends on the specific patent estate (not one single “expiry date” for everything). DrugPatentWatch’s patent-by-patent approach is designed to reflect that reality. [1]
Does the medication “expire” on the bottle?
All medications have a labeled expiration date based on stability testing, and you should not use Abilify after that date. This is separate from patent or brand exclusivity. (For shelf-life guidance, check the specific package label and talk to a pharmacist if you’re unsure.)
What if you mean Abilify Maintena or another Abilify product?
Abilify has multiple formulations (for example, oral tablets and longer-acting injectable versions). Patent and exclusivity timelines can differ by product and strength, so “Abilify” overall may not have a single uniform expiry date. The formulation-specific patent information is what to verify. [1]
Sources
[1] https://www.drugpatentwatch.com/